期刊文献+

微小核糖核酸与前列腺癌 被引量:3

MicroRNAs and prostate cancer
原文传递
导出
摘要 微小核糖核酸(microRNAs,miRNAs)是一类长度约为22个核苷酸,参与基因转录后水平调控的非编码小分子RNA。参与生命的多个过程且与癌症发生发展有着密切的关系。最近研究发现,一些miRNA在前列腺癌(PCa)组织中异常表达,表明miRNA在PCa发病的分子机制中起着重要作用。随着人血清/血浆miRNA的不断深入研究,血清miRNA有望作为诊断PCa的潜在分子标志物。 MicroRNAs(miRNAs),with the length of about 22 nucleotides,are a growing family of small non-protein-coding RNAs that function as post-transcriptional regulators of target genes,involved in multiple processes of life and closely related with tumorigenesis.Recently,some aberrantly expressed miRNAs have been discovered in the prostate,indicating that miRNA may play a critical role in the molecular mechanism of the pathogenesis of prostate cancer.With deeper studies on human serum and plasma miRNAs,serum miRNA is promising to be a potential diagnostic biomarker for prostate cancer.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2010年第9期844-849,共6页 National Journal of Andrology
基金 国家自然科学基金(30950100)~~
关键词 微小核糖核酸 前列腺癌 血清 分子标志物 microRNA prostate cancer serum biomarker
  • 相关文献

参考文献3

二级参考文献98

  • 1潘振伟,吕延杰,初文峰,许超千,白云龙,单宏丽,杨宝峰.缺血性心律失常相关微小RNA在大鼠心脏的表达变化[J].哈尔滨医科大学学报,2007,41(2):95-97. 被引量:7
  • 2Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 3Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 4Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 5Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 6Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 7Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 8Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 9Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 10Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.

共引文献1015

同被引文献41

  • 1艾金霞 ,于秀艳 ,王雪松 .血清hK2 ELISA方法的建立及在前列腺癌诊断中的应用[J].北华大学学报(自然科学版),2005,6(2):125-128. 被引量:4
  • 2丁国芳,李继承,徐银峰,孙瑜,陶莉.中国人前列腺癌VEGF-C mRNA、VEGFR-3和CD31表达与肿瘤转移的关系[J].实验生物学报,2005,38(3):257-264. 被引量:8
  • 3顾平,盛世乐,黄钢.PSA及其它肿瘤标志物在前列腺癌中的应用[J].放射免疫学杂志,2006,19(6):507-512. 被引量:6
  • 4Kohli M, Tindall DJ. New developments in the medical management of prostate cancer[J]. Mayo Clin Proc ,2010,85 ( 1 ) :77-86.
  • 5Roddan AW,Duffy MJ, Hamdy FC,et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10ng/ml: systematic review and meta-analysis[ J]. Eur Uro1,2005,48 ( 3 ) : 386-399.
  • 6Thompson M, Lapointe J, Choi YL, et al. Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle [ J ]. Prostate,2008,68 ( 11 ) : 1248-1256.
  • 7Jennbacken K,Vallbo C, Wang W , et al. Expression of vascular endothelial growth factor ( VEGF-C ) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis[J]. The Prostate,2005,65 (2) : 110-116.
  • 8Sung MT, Jiang Z, Montioni R,et al. Alpha-methylacyl-CoA racemase (P504s)/34 beta E12/p63 triple cocktail stain in prostate ade- nocarcinoma after hormonal therapy [ J ]. Hum Pathol, 2007,38 ( 2 ) : 332-341.
  • 9Luo J, Zha S, Goge WR, et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer [ J ]. Cancer Res, 2002,62 ( 8 ) :2200-2226.
  • 10Jiang Z, Fanger GR, Woda BA, et al. Expression of alpha methylacyl CoA racemase (P504s) in various malignant neoplasmas and normal tissues : a study of 761 case[J]. Hum Pathol, 2003,34 (8) :792-796.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部